BNC

SEC source: 0000921895-26-002756 · form4a14678002_10072026.xml · derivative · entry 4

YZILabs Management Ltd. · CIK 0002098271 · 10% owner

Zhao Changpeng · CIK 0001918995 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,331,877

Underlying: Common Stock, $0.00001 per share · 5,418,633 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price is $0.00001 per share.

F6 · price: The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the "PFW Beneficial Ownership Limitation"). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.

F6 · derivative.exercise_date: The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the "PFW Beneficial Ownership Limitation"). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.

F6 · derivative.expiration_date: The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the "PFW Beneficial Ownership Limitation"). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.

F5 · derivative.underlying_shares: Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the "Beneficial Ownership Limitations"), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.

F2 · ownership.direct: This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · ownership.direct: Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

SEC source: 0000921895-26-002756 · form4a14678002_10072026.xml · derivative · entry 3

YZILabs Management Ltd. · CIK 0002098271 · 10% owner

Zhao Changpeng · CIK 0001918995 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,383,728

Underlying: Common Stock, $0.00001 per share · 2,180,631 shares

Expires 2030-08-05

F1 · derivative.exercise_price: The exercise price is $0.00001 per share.

F4 · price: The Strategic Advisor Warrants are immediately exercisable at an exercise price equal to $0.00001 per share and may be exercised at any point on or prior to 5:00 p.m. on August 5, 2030, subject to the SAW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Strategic Advisor Warrants, the holder may increase or decrease the SAW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 9.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Strategic Advisor Warrants is 9.99% of the Issuer's then outstanding shares of Common Stock (the "SAW Beneficial Ownership Limitation"). On September 17, YZi Labs exercised 2,180,631 Strategic Advisor Warrants, representing 2,180,631 shares of Common Stock, at an exercise price of $0.00001 per share.

F4 · derivative.exercise_date: The Strategic Advisor Warrants are immediately exercisable at an exercise price equal to $0.00001 per share and may be exercised at any point on or prior to 5:00 p.m. on August 5, 2030, subject to the SAW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Strategic Advisor Warrants, the holder may increase or decrease the SAW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 9.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Strategic Advisor Warrants is 9.99% of the Issuer's then outstanding shares of Common Stock (the "SAW Beneficial Ownership Limitation"). On September 17, YZi Labs exercised 2,180,631 Strategic Advisor Warrants, representing 2,180,631 shares of Common Stock, at an exercise price of $0.00001 per share.

F5 · derivative.underlying_shares: Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the "Beneficial Ownership Limitations"), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.

F2 · ownership.direct: This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · ownership.direct: Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

SEC source: 0000921895-26-002756 · form4a14678002_10072026.xml · nonDerivative · entry 2

YZILabs Management Ltd. · CIK 0002098271 · 10% owner

Zhao Changpeng · CIK 0001918995 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,749,745

F1 · price: The exercise price is $0.00001 per share.

F2 · ownership.direct: This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · ownership.direct: Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

SEC source: 0000921895-26-002756 · form4a14678002_10072026.xml · nonDerivative · entry 1

YZILabs Management Ltd. · CIK 0002098271 · 10% owner

Zhao Changpeng · CIK 0001918995 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,331,112

F1 · price: The exercise price is $0.00001 per share.

F2 · ownership.direct: This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · ownership.direct: Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

SEC source: 0000921895-26-002600 · form414678002_09212026.xml · derivative · entry 4

YZILabs Management Ltd. · CIK 0002098271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,331,877

Underlying: Common Stock, $0.00001 per share · 5,418,633 shares

Expires not disclosed

F1 · derivative.exercise_price: The exercise price is $0.00001 per share.

F6 · price: The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the "PFW Beneficial Ownership Limitation"). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.

F6 · derivative.exercise_date: The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the "PFW Beneficial Ownership Limitation"). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.

F6 · derivative.expiration_date: The Pre-Funded Warrants are immediately exercisable at an initial exercise price equal to $0.00001 per share and may be exercised at any time until the Pre-Funded Warrants are exercised in full, subject to the PFW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Pre-Funded Warrants, the holder may increase or decrease the PFW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 19.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Pre-Funded Warrants is 19.99% of the Issuer's then outstanding shares of Common Stock (the "PFW Beneficial Ownership Limitation"). On September 17, 2026, YZi Labs exercised 5,418,633 Pre-Funded Warrants, representing 5,418,633 shares of Common Stock, at an exercise price of $0.00001 per share.

F5 · derivative.underlying_shares: Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the "Beneficial Ownership Limitations"), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.

F2 · ownership.direct: This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · ownership.direct: Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

SEC source: 0000921895-26-002600 · form414678002_09212026.xml · derivative · entry 3

YZILabs Management Ltd. · CIK 0002098271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,383,728

Underlying: Common Stock, $0.00001 per share · 2,180,631 shares

Expires 2030-08-05

F1 · derivative.exercise_price: The exercise price is $0.00001 per share.

F4 · price: The Strategic Advisor Warrants are immediately exercisable at an exercise price equal to $0.00001 per share and may be exercised at any point on or prior to 5:00 p.m. on August 5, 2030, subject to the SAW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Strategic Advisor Warrants, the holder may increase or decrease the SAW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 9.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Strategic Advisor Warrants is 9.99% of the Issuer's then outstanding shares of Common Stock (the "SAW Beneficial Ownership Limitation"). On September 17, YZi Labs exercised 2,180,631 Strategic Advisor Warrants, representing 2,180,631 shares of Common Stock, at an exercise price of $0.00001 per share.

F4 · derivative.exercise_date: The Strategic Advisor Warrants are immediately exercisable at an exercise price equal to $0.00001 per share and may be exercised at any point on or prior to 5:00 p.m. on August 5, 2030, subject to the SAW Beneficial Ownership Limitation (as defined below). Pursuant to the terms of the Strategic Advisor Warrants, the holder may increase or decrease the SAW Beneficial Ownership Limitation upon 61 days' notice to the Issuer, provided that such Beneficial Ownership Limitation in no event exceeds 9.99% of the Issuer's then outstanding shares of Common Stock. As of the date hereof, the Beneficial Ownership Limitation under the Strategic Advisor Warrants is 9.99% of the Issuer's then outstanding shares of Common Stock (the "SAW Beneficial Ownership Limitation"). On September 17, YZi Labs exercised 2,180,631 Strategic Advisor Warrants, representing 2,180,631 shares of Common Stock, at an exercise price of $0.00001 per share.

F5 · derivative.underlying_shares: Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide, or the holder has elected, that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than a certain percentage of the Issuer's then outstanding shares of common stock (the "Beneficial Ownership Limitations"), as adjusted pursuant to the terms of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants. On September 17, 2026, the Issuer agreed to waive the required 61 days' notice period to the Issuer with respect to an increase in the Beneficial Ownership Limitations under the terms of each of the Pre-Funded Warrants and the Strategic Advisor Warrants held by YZi Labs.

F2 · ownership.direct: This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · ownership.direct: Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

SEC source: 0000921895-26-002600 · form414678002_09212026.xml · nonDerivative · entry 2

YZILabs Management Ltd. · CIK 0002098271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,749,745

F1 · price: The exercise price is $0.00001 per share.

F2 · ownership.direct: This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · ownership.direct: Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

SEC source: 0000921895-26-002600 · form414678002_09212026.xml · nonDerivative · entry 1

YZILabs Management Ltd. · CIK 0002098271 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,331,112

F1 · price: The exercise price is $0.00001 per share.

F2 · ownership.direct: This Form 4 is filed jointly by YZiLabs Management Ltd, a British Virgin Islands business company ("YZi Labs") and Changpeng Zhao ("Mr. Zhao"), a citizen of the United Arab Emirates (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that owns more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · ownership.direct: Securities beneficially owned by YZi Labs. As the sole director of YZi Labs, Mr. Zhao may be deemed to beneficially own the securities beneficially owned directly by YZi Labs.

SEC source: 0001493152-26-015912 · ownership.xml · derivative · entry 1

Miller William B · CIK 0001704980 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,636

Underlying: Common Stock · 363,636 shares

Expires not disclosed

F1 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: 25% of the RSUs (90,909 shares) vest on April 6, 2027, with the remaining RSUs vesting in equal quarterly installments thereafter through April 6, 2030, subject to the Participant's continued service with the Company through each applicable vesting date. The RSUs were granted pursuant to the CEA Industries Inc. 2026 Inducement Plan.

F2 · derivative.expiration_date: 25% of the RSUs (90,909 shares) vest on April 6, 2027, with the remaining RSUs vesting in equal quarterly installments thereafter through April 6, 2030, subject to the Participant's continued service with the Company through each applicable vesting date. The RSUs were granted pursuant to the CEA Industries Inc. 2026 Inducement Plan.

SEC source: 0001493152-26-008601 · ownership.xml · derivative · entry 3

Thomas Hans · CIK 0001828707 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By 10X Capital Partners LLC

Disclosed balance after: 390,099

Underlying: Common Stock · 250,000 shares

Expires 2030-08-05

F3 · deemedExecutionDate: Reflects the effective assignment of such warrants to a third-party.

F4 · ownership.nature: Reporting Person is the manager of 10X Capital Partners LLC and may be deemed to have beneficial ownership of the securities held by 10X Capital Partners LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001493152-26-008601 · ownership.xml · derivative · entry 6

Thomas Hans · CIK 0001828707 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By 10X LLC

Disclosed balance after: 0

Underlying: Common Stock · 831,683 shares

Expires 2032-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · deemedExecutionDate: Reflects the exercise of certain warrants for shares of common stock.

F2 · ownership.nature: Reporting Person is the manager of 10X LLC and may be deemed to have beneficial ownership of the securities held by 10X LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001493152-26-008601 · ownership.xml · nonDerivative · entry 1

Thomas Hans · CIK 0001828707 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By 10X LLC

Disclosed balance after: 831,683

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · deemedExecutionDate: Reflects the exercise of certain warrants for shares of common stock.

F2 · ownership.nature: Reporting Person is the manager of 10X LLC and may be deemed to have beneficial ownership of the securities held by 10X LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001493152-25-029150 · ownership.xml · derivative · entry 3

Read Russell · CIK 0001889678 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,330

Underlying: Common Stock · 1,330 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F4 · shares: 1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

F4 · derivative.exercise_date: 1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

F4 · derivative.expiration_date: 1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

SEC source: 0001493152-25-029150 · ownership.xml · derivative · entry 2

Read Russell · CIK 0001889678 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,660

Underlying: Common Stock · 2,660 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F3 · shares: Represents the grant of 2,660 RSUs issued pursuant to the Company's compensation plan for independent directors effective December 16, 2024, and subject to the terms and restrictions of the Agreement.

F4 · derivative.exercise_date: 1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

F4 · derivative.expiration_date: 1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

SEC source: 0001493152-25-029150 · ownership.xml · nonDerivative · entry 1

Read Russell · CIK 0001889678 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,330

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: On October 7, 2025, 1,330 restricted stock units ("RSUs") were vested in accordance with the vesting schedule in the Restricted Stock Unit Agreement ("Agreement").

SEC source: 0001493152-25-029140 · ownership.xml · derivative · entry 3

Howard Carly E · CIK 0002092040 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,330

Underlying: Common Stock · 1,330 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F4 · shares: 1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

F4 · derivative.exercise_date: 1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

F4 · derivative.expiration_date: 1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

SEC source: 0001493152-25-029140 · ownership.xml · derivative · entry 2

Howard Carly E · CIK 0002092040 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,660

Underlying: Common Stock · 2,660 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis.

F3 · shares: Represents the grant of 2,660 RSUs issued pursuant to the Company's compensation plan for independent directors effective December 16, 2024, and subject to the terms and restrictions of the Agreement.

F4 · derivative.exercise_date: 1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

F4 · derivative.expiration_date: 1,330 RSUs vested on October 7,2025, and 1,330 RSUs will vest on October 7, 2026, subject to continued service through such date.

SEC source: 0001493152-25-029140 · ownership.xml · nonDerivative · entry 1

Howard Carly E · CIK 0002092040 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,330

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: On October 7, 2025, 1,330 restricted stock units ("RSUs") were vested in accordance with the vesting schedule in the Restricted Stock Unit Agreement ("Agreement").

SEC source: 0001493152-25-017199 · ownership.xml · nonDerivative · entry 1

McDonald Anthony K · CIK 0001454332 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,025

F1 · price: Represents the weighted average price of the shares purchased on the open market. The prices of the shares purchased pursuant to the transaction ranged from $8.52 to $8.70 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

SEC source: 0001493152-25-016862 · ownership.xml · nonDerivative · entry 1

McDonald Anthony K · CIK 0001454332 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,177

SEC source: 0001493152-26-008601 · ownership.xml · derivative · entry 5

Thomas Hans · CIK 0001828707 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By 10X LLC

Disclosed balance after: 831,683

Underlying: Common Stock · 831,683 shares

Expires 2032-08-05

F7 · deemedExecutionDate: On October 1, 2025, 10X LLC received 831,683 Strategic Advisor Warrants that were assigned from 10X BNB Cayman Sponsor. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F2 · ownership.nature: Reporting Person is the manager of 10X LLC and may be deemed to have beneficial ownership of the securities held by 10X LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001493152-26-008601 · ownership.xml · derivative · entry 4

Thomas Hans · CIK 0001828707 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By 10X BNB Cayman Sponsor

Disclosed balance after: 0

Underlying: Common Stock · 2,376,239 shares

Expires 2032-08-05

F5 · deemedExecutionDate: On October 1, 2025, 10X BNB Cayman Sponsor transferred and assigned 100% of its Strategic Advisor Warrants to certain members of 10X BNB Cayman Sponsor and third-parties, resulting in 10X BNB Cayman Sponsor beneficially owning no warrants following the transaction. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F6 · ownership.nature: Reporting Person was the manager of 10X BNB Cayman Sponsor and may be deemed to have beneficial ownership of the securities held by 10X BNB Cayman Sponsor. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001493152-26-008601 · ownership.xml · derivative · entry 2

Thomas Hans · CIK 0001828707 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By 10X Capital Partners LLC

Disclosed balance after: 640,099

Underlying: Common Stock · 350,000 shares

Expires 2030-08-05

F3 · deemedExecutionDate: Reflects the effective assignment of such warrants to a third-party.

F4 · ownership.nature: Reporting Person is the manager of 10X Capital Partners LLC and may be deemed to have beneficial ownership of the securities held by 10X Capital Partners LLC. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

SEC source: 0001641172-25-022372 · ownership.xml · derivative · entry 2

Tarallo Matthew · CIK 0002048813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,529 shares

Expires 2025-08-05

SEC source: 0001641172-25-022372 · ownership.xml · nonDerivative · entry 1

Tarallo Matthew · CIK 0002048813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,058

SEC source: 0001641172-25-021468 · ownership.xml · derivative · entry 2

Tarallo Matthew · CIK 0002048813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,790

Underlying: Common Stock · 5,790 shares

Expires not disclosed

F2 · deemedExecutionDate: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 1, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · shares: Represents the grant of 5,790 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F2 · derivative.exercise_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 1, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F2 · derivative.expiration_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 1, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · derivative.underlying_shares: Represents the grant of 5,790 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F1 · balance_after: Represents the grant of 5,790 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

SEC source: 0001641172-25-021470 · ownership.xml · derivative · entry 2

ETTEN NICHOLAS J. · CIK 0001814418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,669

Underlying: Common Stock · 119,669 shares

Expires not disclosed

F2 · deemedExecutionDate: The Restricted Stock Units will vest on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · shares: Represents the grant of 119,669 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity retention award.

F2 · derivative.exercise_date: The Restricted Stock Units will vest on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F2 · derivative.expiration_date: The Restricted Stock Units will vest on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · derivative.underlying_shares: Represents the grant of 119,669 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity retention award.

F1 · balance_after: Represents the grant of 119,669 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity retention award.

SEC source: 0001641172-25-021464 · ownership.xml · derivative · entry 2

Shipley James Randall · CIK 0001814398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,507

Underlying: Common Stock · 96,507 shares

Expires not disclosed

F2 · deemedExecutionDate: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 1, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · shares: Represents the grant of 96,507 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F2 · derivative.exercise_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 1, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F2 · derivative.expiration_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 1, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · derivative.underlying_shares: Represents the grant of 96,507 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F1 · balance_after: Represents the grant of 96,507 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

SEC source: 0001641172-25-021466 · ownership.xml · derivative · entry 2

Mariathasan Marion · CIK 0001905775 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,533

Underlying: Common Stock · 40,533 shares

Expires not disclosed

F2 · deemedExecutionDate: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 1, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · shares: Represents the grant of 40,533 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F2 · derivative.exercise_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 1, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F2 · derivative.expiration_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 1, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · derivative.underlying_shares: Represents the grant of 40,533 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F1 · balance_after: Represents the grant of 40,533 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

SEC source: 0001641172-25-021462 · ownership.xml · derivative · entry 2

McDonald Anthony K · CIK 0001454332 · Director · CEO President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,125

Underlying: Common Stock · 223,125 shares

Expires not disclosed

F2 · deemedExecutionDate: The Restricted Stock Units will vest on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · shares: Represents the grant of 223,125 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity retention award.

F2 · derivative.exercise_date: The Restricted Stock Units will vest on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F2 · derivative.expiration_date: The Restricted Stock Units will vest on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · derivative.underlying_shares: Represents the grant of 223,125 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity retention award.

F1 · balance_after: Represents the grant of 223,125 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity retention award.

SEC source: 0001641172-25-022376 · ownership.xml · derivative · entry 2

Tarallo Matthew · CIK 0002048813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,790

Underlying: Common Stock · 5,790 shares

Expires not disclosed

F2 · deemedExecutionDate: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · shares: Represents the grant of 5,790 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F2 · derivative.exercise_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F2 · derivative.expiration_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · derivative.underlying_shares: Represents the grant of 5,790 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F1 · balance_after: Represents the grant of 5,790 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

SEC source: 0001641172-25-022380 · ownership.xml · derivative · entry 2

Shipley James Randall · CIK 0001814398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,507

Underlying: Common Stock · 96,507 shares

Expires not disclosed

F2 · deemedExecutionDate: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · shares: Represents the grant of 96,507 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F2 · derivative.exercise_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F2 · derivative.expiration_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · derivative.underlying_shares: Represents the grant of 96,507 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F1 · balance_after: Represents the grant of 96,507 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

SEC source: 0001641172-25-022378 · ownership.xml · derivative · entry 2

Mariathasan Marion · CIK 0001905775 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,533

Underlying: Common Stock · 40,533 shares

Expires not disclosed

F2 · deemedExecutionDate: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · shares: Represents the grant of 40,533 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F2 · derivative.exercise_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F2 · derivative.expiration_date: The Restricted Stock Units will vest (i) only if the Recipient's employment as a director has been terminated by resignation or other wise before the close of business on August 5, 2025, and (ii) on the next business day after the approval of the Plan by the shareholders of the Company pursuant to state and federal law.

F1 · derivative.underlying_shares: Represents the grant of 40,533 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

F1 · balance_after: Represents the grant of 40,533 restricted stock units issued under the Company's 2025 Equity Incentive Plan ("the Plan") as an equity severance award.

SEC source: 0001493152-25-000215 · ownership.xml · nonDerivative · entry 1

ETTEN NICHOLAS J. · CIK 0001814418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,347

SEC source: 0001493152-25-000217 · ownership.xml · nonDerivative · entry 1

Shipley James Randall · CIK 0001814398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,079

SEC source: 0001493152-25-000216 · ownership.xml · nonDerivative · entry 1

Mariathasan Marion · CIK 0001905775 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,628

SEC source: 0001493152-24-050851 · ownership.xml · derivative · entry 2

Tarallo Matthew · CIK 0002048813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,529

Underlying: Common Stock · 1,529 shares

Expires 2025-12-17

SEC source: 0001493152-24-050851 · ownership.xml · nonDerivative · entry 1

Tarallo Matthew · CIK 0002048813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,529

SEC source: 0001493152-24-049638 · ownership.xml · nonDerivative · entry 6

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,947

SEC source: 0001493152-24-049638 · ownership.xml · nonDerivative · entry 5

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,583

SEC source: 0001493152-24-049638 · ownership.xml · nonDerivative · entry 4

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,284

SEC source: 0001493152-24-049638 · ownership.xml · nonDerivative · entry 3

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,984

SEC source: 0001493152-24-049638 · ownership.xml · nonDerivative · entry 2

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,234

SEC source: 0001493152-24-049638 · ownership.xml · nonDerivative · entry 1

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,734

SEC source: 0001493152-24-049636 · ownership.xml · nonDerivative · entry 4

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,834

SEC source: 0001493152-24-049636 · ownership.xml · nonDerivative · entry 3

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,334

SEC source: 0001493152-24-049636 · ownership.xml · nonDerivative · entry 2

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,584

SEC source: 0001493152-24-049636 · ownership.xml · nonDerivative · entry 1

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,047

SEC source: 0001493152-24-049463 · ownership.xml · nonDerivative · entry 3

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,584

SEC source: 0001493152-24-049463 · ownership.xml · nonDerivative · entry 2

McDonald Anthony K · CIK 0001454332 · Director · CEO/President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,434